In vitro evaluation of the antibacterial activity of amitriptyline and its synergistic effect with ciprofloxacin, sulfamethoxazole–trimethoprim, and colistin as an alternative in drug repositioning

2019 ◽  
Vol 29 (1) ◽  
pp. 166-177
Author(s):  
Catrine de S. Machado ◽  
Tacieli F. da Rosa ◽  
Marissa B. Serafin ◽  
Angelita Bottega ◽  
Silvana S. Coelho ◽  
...  
2018 ◽  
Vol 15 (3) ◽  
Author(s):  
Israeliane F. Cordeiro ◽  
Henrique D. M. Coutinho ◽  
Joao V. A. Ferreira ◽  
Lucindo J. Quintans Junior ◽  
Irwin R. A. Menezes ◽  
...  

Polymers ◽  
2019 ◽  
Vol 11 (7) ◽  
pp. 1186 ◽  
Author(s):  
Ilkay Karakurt ◽  
Kadir Ozaltin ◽  
Daniela Vesela ◽  
Marian Lehocky ◽  
Petr Humpolíček ◽  
...  

Polylactic acid (PLA) is one of the most produced polymeric materials, due to its exceptional chemical and mechanical properties. Some of them, such as biodegradability and biocompatibility, make them attractive for biomedical applications. Conversely, the major drawback of PLA in the biomedical field is their vulnerability to bacterial contamination. This study focuses on the immobilization of saccharides onto the PLA surface by a multistep approach, with the aim of providing antibacterial features and evaluting the synergistic effect of these saccharides. In this approach, after poly (acrylic acid) (PAA) brushes attached non-covalently to the PLA surface via plasma post-irradiation grafting technique, immobilization of glucosamine (GlcN) and chondroitin sulfate (ChS) to the PAA brushes was carried out. To understand the changes in surface properties, such as chemical composition, surface topography and hydrophilicity, the untreated and treated PLA films were analyzed using various characterization techniques (contact angle, scanning electron microscopy, X-ray photoelectron spectroscopy). In vitro cytotoxicity assays were investigated by the methyl tetrazolium test. The antibacterial activity of the PLA samples was tested against Escherichia coli and Staphylococcus aureus bacteria strains. Plasma-treated films immobilized with ChS and GlcN, separately and in combination, demonstrated bactericidal effect against the both bacteria strains and also the results revealed that the combination has no synergistic effect on antibacterial action.


Author(s):  
BA Ukorebi ◽  
ABI Udedibie ◽  
BO Esonu ◽  
IC Okoli ◽  
A Essien

2021 ◽  
Vol 14 (2) ◽  
pp. 077-086
Author(s):  
Oluremi Adejoke Akinwale ◽  
Uyi Oluwatobi Emokpae ◽  
Opeyemi Mariam Adebogun ◽  
Morenike Olutumbi Adeoye-Isijola ◽  
Olufunmiso Olusola Olajuyigbe

The study investigated the in vitro effects of quinine on the antibacterial activity of erythromycin for possible interactions. The antibacterial activities of each drug and their combinations were investigated by agar diffusion, agar and macrobroth dilution methods. While 100 µl of 1000 µg/ml of erythromycin produced inhibition zones ranging between 13 and 31 ± 1.0 mm in all the isolates except K. pneumoniae and P. aeruginosa ATCC 19582, combining the highest concentration of erythromycin with 35 µg/ml of quinine produced inhibition zones ranging between 14 and 34 ± 1.0 mm with the exception of S. flexneri KZN. Though quinine had no antibacterial effects on the isolates, erythromycin was effective at minimum inhibitory concentrations (MICs) ranging between 25 and 100 µg/ml while their combinations resulted in reduction of MICs of most of the isolates to 12.5 µg/ml except those against A. calcaoceuticus anitratus CSIR, Ps. aeruginosa ATCC 15442, P. shigelloides ATCC 51903, A. hydrophila ATCC 35654, Ps. aeruginosa ATCC 19582 and E. faecalis KZN that remained unchanged in agar dilution. While the MICs of erythromycin ranged between 25 and 50 µg/ml, the MICs of this antibiotic was reduced to concentrations ranging between 12.5 and 50 µg/ml indicating 50% to 75% in the presence of quinine. The combination of erythromycin and quinine, in vitro, resulted in synergistic (50%), additive/indifference (44.44%) and antagonistic (11.11%) interactions while quinine at concentrations lower than plasma quinine concentrations was inhibitory to the antibacterial activity of erythromycin. The synergistic effect may serve as remedy for bacterial infections in which the test bacteria have been implicated.


Sign in / Sign up

Export Citation Format

Share Document